
In 2024, the global market size of Intranasal Drug Delivery Devices was estimated to be worth US$ 1406 million and is forecast to reach approximately US$ 2890 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
North America is the largest region of Intranasal Drug Delivery Devices, with a market share about 40%. It was followed by Europe with 35%. BD, AptarGroup, 3M Company, Teleflex, H&T Presspart and Bespak are the top 6 manufacturers of industry, and they had about 85% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intranasal Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Drug Delivery Devices.
The Intranasal Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intranasal Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intranasal Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
BD
AptarGroup
3M
Teleflex
H&T Presspart
Bespak
SegmentÌýby Type
Multidose
Uni/bidose
SegmentÌýby Application
Personal Use
Hospital Use
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intranasal Drug Delivery Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Intranasal Drug Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intranasal Drug Delivery Devices sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Intranasal Drug Delivery Devices Product Introduction
1.2 Market by Type
1.2.1 Global Intranasal Drug Delivery Devices Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Multidose
1.2.3 Uni/bidose
1.3 Market by Application
1.3.1 Global Intranasal Drug Delivery Devices Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Personal Use
1.3.3 Hospital Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intranasal Drug Delivery Devices Market Size Estimates and Forecasts
2.1.1 Global Intranasal Drug Delivery Devices Revenue 2020-2031
2.1.2 Global Intranasal Drug Delivery Devices Sales 2020-2031
2.2 Intranasal Drug Delivery Devices Market Size by Region: 2024 Versus 2031
2.3 Intranasal Drug Delivery Devices Sales by Region (2020-2031)
2.3.1 Global Intranasal Drug Delivery Devices Sales by Region: 2020-2025
2.3.2 Global Intranasal Drug Delivery Devices Sales Forecast by Region (2026-2031)
2.3.3 Global Intranasal Drug Delivery Devices Sales Market Share by Region (2020-2031)
2.4 Intranasal Drug Delivery Devices Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Intranasal Drug Delivery Devices Revenue by Region: 2020-2025
2.4.2 Global Intranasal Drug Delivery Devices Revenue Forecast by Region (2026-2031)
2.4.3 Global Intranasal Drug Delivery Devices Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Intranasal Drug Delivery Devices Sales by Type (2020-2031)
3.1.1.1 Global Intranasal Drug Delivery Devices Sales Volume by Type (2020-2031)
3.1.1.2 Global Intranasal Drug Delivery Devices Sales Market Share by Type (2020-2031)
3.1.2 Global Intranasal Drug Delivery Devices Revenue by Type (2020-2031)
3.1.2.1 Global Intranasal Drug Delivery Devices Revenue by Type (2020-2031)
3.1.2.2 Global Intranasal Drug Delivery Devices Revenue Market Share by Type (2020-2031)
3.1.3 Intranasal Drug Delivery Devices Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Intranasal Drug Delivery Devices Sales by Application (2020-2031)
3.2.1.1 Global Intranasal Drug Delivery Devices Sales Volume by Application (2020-2031)
3.2.1.2 Global Intranasal Drug Delivery Devices Sales Market Share by Application (2020-2031)
3.2.2 Global Intranasal Drug Delivery Devices Revenue by Application (2020-2031)
3.2.2.1 Global Intranasal Drug Delivery Devices Revenue by Application (2020-2031)
3.2.2.2 Global Intranasal Drug Delivery Devices Revenue Market Share by Application (2020-2031)
3.2.3 Intranasal Drug Delivery Devices Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Multidose of Intranasal Drug Delivery Devices Revenue Market Share by Application
3.3.2 Uni/bidose of Intranasal Drug Delivery Devices Revenue Market Share by Application
4 Global Intranasal Drug Delivery Devices by Manufacturers
4.1 Global Top Intranasal Drug Delivery Devices Manufacturers by Sales (2020-2025)
4.1.1 Global Intranasal Drug Delivery Devices Sales by Manufacturer (2020-2025)
4.1.2 Global Intranasal Drug Delivery Devices Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Intranasal Drug Delivery Devices Manufacturers by Revenue (2020-2025)
4.2.1 Global Intranasal Drug Delivery Devices Revenue by Manufacturer (2020-2025)
4.2.2 Global Intranasal Drug Delivery Devices Revenue Share by Manufacturer (2020-2025)
4.3 Global Intranasal Drug Delivery Devices Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Intranasal Drug Delivery Devices Manufacturers Covered: Ranking by Revenue
4.4.2 Global Intranasal Drug Delivery Devices Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Intranasal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Intranasal Drug Delivery Devices Manufacturing Base Distribution, Product Type
4.5.1 Intranasal Drug Delivery Devices Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Intranasal Drug Delivery Devices Market
4.5.3 Manufacturers Intranasal Drug Delivery Devices Product Type and Application
4.5.4 Multidose Market Sales of Intranasal Drug Delivery Devices by Manufacturer
4.5.5 Uni/bidose Market Sales of Intranasal Drug Delivery Devices by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 BD
5.1.1 BD Company Information
5.1.2 BD Description, Business Overview
5.1.3 BD Intranasal Drug Delivery Devices Products Offered
5.1.4 BD Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
5.1.5 BD Intranasal Drug Delivery Devices Sales by Product in 2024
5.1.6 BD Intranasal Drug Delivery Devices Sales by Application in 2024
5.1.7 BD Intranasal Drug Delivery Devices Sales by Geographic Area in 2024
5.1.8 BD Recent Developments
5.2 AptarGroup
5.2.1 AptarGroup Company Information
5.2.2 AptarGroup Description, Business Overview
5.2.3 AptarGroup Intranasal Drug Delivery Devices Products Offered
5.2.4 AptarGroup Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
5.2.5 AptarGroup Intranasal Drug Delivery Devices Sales by Product in 2024
5.2.6 AptarGroup Intranasal Drug Delivery Devices Sales by Application in 2024
5.2.7 AptarGroup Intranasal Drug Delivery Devices Sales by Geographic Area in 2024
5.2.8 AptarGroup Recent Developments
5.3 3M
5.3.1 3M Company Information
5.3.2 3M Description, Business Overview
5.3.3 3M Intranasal Drug Delivery Devices Products Offered
5.3.4 3M Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
5.3.5 3M Intranasal Drug Delivery Devices Sales by Product in 2024
5.3.6 3M Intranasal Drug Delivery Devices Sales by Application in 2024
5.3.7 3M Intranasal Drug Delivery Devices Sales by Geographic Area in 2024
5.3.8 3M Recent Developments
5.4 Teleflex
5.4.1 Teleflex Company Information
5.4.2 Teleflex Description, Business Overview
5.4.3 Teleflex Intranasal Drug Delivery Devices Products Offered
5.4.4 Teleflex Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Teleflex Intranasal Drug Delivery Devices Sales by Product in 2024
5.4.6 Teleflex Intranasal Drug Delivery Devices Sales by Application in 2024
5.4.7 Teleflex Intranasal Drug Delivery Devices Sales by Geographic Area in 2024
5.4.8 Teleflex Recent Developments
5.5 H&T Presspart
5.5.1 H&T Presspart Company Information
5.5.2 H&T Presspart Description, Business Overview
5.5.3 H&T Presspart Intranasal Drug Delivery Devices Products Offered
5.5.4 H&T Presspart Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
5.5.5 H&T Presspart Intranasal Drug Delivery Devices Sales by Product in 2024
5.5.6 H&T Presspart Intranasal Drug Delivery Devices Sales by Application in 2024
5.5.7 H&T Presspart Intranasal Drug Delivery Devices Sales by Geographic Area in 2024
5.5.8 H&T Presspart Recent Developments
5.6 Bespak
5.6.1 Bespak Company Information
5.6.2 Bespak Description, Business Overview
5.6.3 Bespak Intranasal Drug Delivery Devices Products Offered
5.6.4 Bespak Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Bespak Intranasal Drug Delivery Devices Sales by Product in 2024
5.6.6 Bespak Intranasal Drug Delivery Devices Sales by Application in 2024
5.6.7 Bespak Intranasal Drug Delivery Devices Sales by Geographic Area in 2024
5.6.8 Bespak Recent Developments
6 North America
6.1 North America Intranasal Drug Delivery Devices Market Size YoY Growth 2020-2031
6.2 North America Intranasal Drug Delivery Devices Market Facts & Figures by Country
6.2.1 North America Intranasal Drug Delivery Devices Sales by Country (2020-2031)
6.2.2 North America Intranasal Drug Delivery Devices Revenue by Country (2020-2031)
6.3 North America Intranasal Drug Delivery Devices Sales by Type (2020-2025)
6.4 North America Intranasal Drug Delivery Devices Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Intranasal Drug Delivery Devices Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Intranasal Drug Delivery Devices Market Facts & Figures by Region
7.2.1 Asia-Pacific Intranasal Drug Delivery Devices Sales by Region (2020-2031)
7.2.2 Asia-Pacific Intranasal Drug Delivery Devices Revenue by Region (2020-2031)
7.3 Asia-Pacific Intranasal Drug Delivery Devices Sales by Type (2020-2025)
7.4 Asia-Pacific Intranasal Drug Delivery Devices Sales by Application (2020-2025)
8 Europe
8.1 Europe Intranasal Drug Delivery Devices Market Size YoY Growth 2020-2031
8.2 Europe Intranasal Drug Delivery Devices Market Facts & Figures by Country
8.2.1 Europe Intranasal Drug Delivery Devices Sales by Country (2020-2031)
8.2.2 Europe Intranasal Drug Delivery Devices Revenue by Country (2020-2031)
8.3 Europe Intranasal Drug Delivery Devices Sales by Type (2020-2025)
8.4 Europe Intranasal Drug Delivery Devices Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Intranasal Drug Delivery Devices Market Size YoY Growth 2020-2031
9.2 Latin America Intranasal Drug Delivery Devices Market Facts & Figures by Country
9.2.1 Latin America Intranasal Drug Delivery Devices Sales by Country (2020-2031)
9.2.2 Latin America Intranasal Drug Delivery Devices Revenue by Country (2020-2031)
9.3 Latin America Intranasal Drug Delivery Devices Sales by Type (2020-2025)
9.4 Latin America Intranasal Drug Delivery Devices Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Intranasal Drug Delivery Devices Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Intranasal Drug Delivery Devices Market Facts & Figures by Country
10.2.1 Middle East and Africa Intranasal Drug Delivery Devices Sales by Country (2020-2031)
10.2.2 Middle East and Africa Intranasal Drug Delivery Devices Revenue by Country (2020-2031)
10.3 Middle East and Africa Intranasal Drug Delivery Devices Sales by Type (2020-2025)
10.4 Middle East and Africa Intranasal Drug Delivery Devices Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Intranasal Drug Delivery Devices Supply Chain Analysis
11.2 Intranasal Drug Delivery Devices Key Raw Materials and Upstream Suppliers
11.3 Intranasal Drug Delivery Devices Clients Analysis
11.4 Intranasal Drug Delivery Devices Sales Channel and Sales Model Analysis
11.4.1 Intranasal Drug Delivery Devices Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Intranasal Drug Delivery Devices Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Intranasal Drug Delivery Devices Distributors
12 Intranasal Drug Delivery Devices Market Dynamics
12.1 Intranasal Drug Delivery Devices Industry Trends
12.2 Intranasal Drug Delivery Devices Market Drivers
12.3 Intranasal Drug Delivery Devices Market Challenges
12.4 Intranasal Drug Delivery Devices Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
BD
AptarGroup
3M
Teleflex
H&T Presspart
Bespak
Ìý
Ìý
*If Applicable.
